Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 13, 2021
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced the appointment of Dr. Christian Schetter, Ph.D. as Chief Scientific Officer (CSO) of Rentschler Biopharma SE, where ...
read more
Rentschler Biopharma, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced the appointment of Thomas aus dem Siepen as Global Head Digital Manufacturing and Automation, effective April 1, 2023.
read more
Rentschler Biopharma SE announced the appointment of Robert Panting, Ph.D., to the newly created position of Vice President Global Client Program Management (CPM) and Strategy, effective immediately.
read more
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the company has broken ground at its new production site, adjacent to its existing site in Milford, MA in the ...
read more
Monday, November 21, 2022
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced, that following seven years of accelerated growth at Rentschler Biopharma under his leadership as Chief Executive ...
read more
Rentschler Biopharma announced the company has completed the acquisition of a manufacturing facility from an affiliate of Shire.
read more
Wednesday, March 06, 2024
In 2023, the FDA Center for Drug Evaluation and Research (CDER) approved 55 new drugs, 17 of which were biopharmaceuticals. Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, ...
read more
Wednesday, February 17, 2021
Rentschler Biopharma announced the Company is establishing a Center of Excellence for cell and gene therapy, which will be located in Stevenage, UK.
read more
Rentschler Biopharma has entered into a collaboration with Genmab for the development and manufacture of bispecific antibodies generated with Genmab’s DuoBody technology platform.
read more
Thursday, February 03, 2022
Rentschler Biopharma announced that the company has further strengthened its Leadership Team with the hiring of several senior level, highly experienced biopharmaceutical executives.
read more
Wednesday, March 28, 2018
Rentschler Biopharma SE announced Dr. Thomas Rösch will join the company as Vice President Biopharma Engineering & Technology, effective April 1, 2018.
read more
Tuesday, September 03, 2024
Rentschler Biopharma SE announced the launch of an expanded service offering at its dedicated advanced therapies site in Stevenage, UK. This enhancement introduces a new lentiviral vector manufacturing (LVV) toolbox, complementing the company’s ...
read more
Rentschler Biopharma and Horizon Discovery announced the signing of a commercial license agreement.
read more
Rentschler Biopharma announced Prof. Dr. Nikolaus F. Rentschler, and CEO Dr. Frank Mathias have received the "EY Entrepreneur of the Year" Award 2019 in the category Industry.
read more
Wednesday, December 20, 2023
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a major client collaboration for its upcoming Rentschler Biopharma Manufacturing Center (RBMC) ...
read more